Transgenic Mouse Technology in Skin Biology: Generation of Complete or Tissue- Specific Knockout Mice  Lukas Scharfenberger, Tina Hennerici, Gábor Király,

Slides:



Advertisements
Similar presentations
Troubling News… …in Genetics?. Genetics and Behavior Reverse Genetic Analysis.
Advertisements

Next lecture:techniques used to study the role of genes in develpoment Random genetics followed by screening Targeted mutagenesis (gene knockout) Transgenic.
4.ESCs microinjection in 8-cell stage embryo 5. Chimeric pups Design and generation of a glutaminase Gls2 conditional knockout mice A. Peñalver 1, M. Tosina.
Transgenic Mouse: Generic term for an engineered mouse that has a normal DNA sequence for a gene replaced by an engineered sequence or a sequence from.
Mouse as a Model Organism Tuesday, February 7, 2012.
Knockout and transgenic mice: uses and abuses
MCDB 4650 Mouse Developmental Genetics and Genetic Engineering.
DNA Chips Attach DNA to tiny spots on glass slides (i.e., chip). Hybridize fluorescently-labeled DNA probes to chip. Detect hybridization to different.
Conditional Knockout and Recombinant Cre/loxP, Flp/FRT System
Embryonic Stem Cell Method
Recombinant DNA Technology CHMI 4226 E Week of April 30, 2009 Functional genomics Transgenic mice Knock-out mice.
Research Techniques Made Simple: Generation of complete or tissue-specific knockout mice Lukas Scharfenberger, Tina Hennerici, Gábor Király, Sophie Kitzmüller,
"knockout mouse" homologous recombination
1 Coding region ATG: Translation start Translation stop Transcription start (mRNA start) (mRNA end) poly-adenylation exon intron Mature mRNA Gene structure.
A LOOK AT GENETICALLY MODIFIED ANIMALS CREATED FOR BETTER USE BY HUMANS. Part of Project by David Klodowski.
Genetically Engineered Mouse Models of Prostate Cancer
Haydn Prosser, Sohaila Rastan  Trends in Biotechnology 
18. Transgenic Models.
Gene Knockout 査向东 安徽大学生命科学学院.
Supplementary Figure S1 Generation of Nphp3G2A knock-in mice
A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII by Scot A. Fahs, Matthew.
Vascular Endothelial-Specific Dimethylarginine Dimethylaminohydrolase-1–Deficient Mice Reveal That Vascular Endothelium Plays an Important Role in Removing.
Troubling News… …in Genetics?.
Role of AP1/NFE2 binding sites in endogenous α-globin gene transcription by Melanie R. Loyd, Yasuhiro Okamoto, Mindy S. Randall, and Paul A. Ney Blood.
Supplementary Figure S12
Transgenic Mouse Technology in Skin Biology: Inducible Gene Knockout in Mice  Christian Günschmann, Elena Chiticariu, Bhavuk Garg, Merve Meliha Hiz, Yora.
Volume 140, Issue 2, Pages e2 (February 2011)
Lineage Tracing Mediated by Cre-Recombinase Activity
Mouse Models in Preclinical Studies for Pachyonychia Congenita
The murine platelet and plasma factor V pools are biosynthetically distinct and sufficient for minimal hemostasis by Hongmin Sun, Tony L. Yang, Angela.
Relationship between Genotype and Phenotype
Next-Generation Sequencing: Methodology and Application
Β1 Integrins with Individually Disrupted Cytoplasmic NPxY Motifs Are Embryonic Lethal but Partially Active in the Epidermis  Alexander Meves, Christopher.
Volume 9, Issue 2, Pages (January 2003)
Induction of Thymic Stromal Lymphopoietin Expression in Keratinocytes Is Necessary for Generating an Atopic Dermatitis upon Application of the Active.
Functional Analysis of Genes
Wanglong Qiu, Xiaojun Li, Hongyan Tang, Alicia S. Huang, Andrey A
Genetically Engineered Mouse Models of Prostate Cancer
Epidermal Differentiation: Transgenic/Knockout Mouse Models Reveal Genes Involved in Stem Cell Fate Decisions and Commitment to Differentiation  Maranke.
Transgenic Mouse Technology in Skin Biology: Generation of Knockin Mice  Frederik Tellkamp, Farida Benhadou, Jeroen Bremer, Maria Gnarra, Jana Knüver,
Relationship between Genotype and Phenotype
Metabolic Pitfalls of CNS Cre-Based Technology
Volume 154, Issue 6, Pages (September 2013)
Volume 10, Issue 1, Pages (July 2009)
Naokazu Inoue, Ph. D. , Takao Nishikawa, M. S. , Masahito Ikawa, Ph. D
Hitomi Aoki, Hiroyuki Tomita, Akira Hara, Takahiro Kunisada 
Andriana G Kotini, Michel Sadelain, Eirini P Papapetrou 
Volume 140, Issue 2, Pages e2 (February 2011)
Ahnak/Desmoyokin Is Dispensable for Proliferation, Differentiation, and Maintenance of Integrity in Mouse Epidermis  Michiyoshi Kouno, Gen Kondoh, Kyoji.
Minutes of the Board of Directors Meeting
Volume 128, Issue 1, Pages 9-13 (January 2007)
Targeted disruption of the Nijmegen breakage syndrome gene NBS1 leads to early embryonic lethality in mice  Jie Zhu, Simone Petersen, Lino Tessarollo,
Targeted Mutagenesis of the Endogenous Mouse Mis Gene Promoter
Β-globin Gene Switching and DNase I Sensitivity of the Endogenous β-globin Locus in Mice Do Not Require the Locus Control Region  M.A Bender, Michael.
Gene Targeting in Embryonic Stem Cells Scores a Knockout in Stockholm
Volume 12, Issue 3, Pages (September 2010)
Society for Investigative Dermatology 2010 Meeting Minutes
Multiple Developmental Stage–Specific Enhancers Regulate CD8 Expression in Developing Thymocytes and in Thymus-Independent T Cells  Wilfried Ellmeier,
Mouse Models in Preclinical Studies for Pachyonychia Congenita
Generation of Siva conditional knockout mice.
Figure 1. Kidney-Specific Cre/loxP Recombination.
Volume 12, Issue 3, Pages (September 2010)
Production of Mapk14 and Mapk7 KO cells.
Deletion of Srf with a skeletal muscle-specific Cre transgene.
Targeted disruption of the RapGEF2 gene.
Fig. 4. Targeted disruption of STK35 transcripts in mouse.
Fig. 1. Generation of WNK3 knockout mice
2012 William Allan Award: Adventures in Cytogenetics1
A 3′ UTR Modification of the Mitochondrial Rieske Iron Sulfur Protein in Mice Produces a Specific Skin Pigmentation Phenotype  Sofia Garcia, Francisca.
Kevin Huang, Guoping Fan  Cell Stem Cell 
Presentation transcript:

Transgenic Mouse Technology in Skin Biology: Generation of Complete or Tissue- Specific Knockout Mice  Lukas Scharfenberger, Tina Hennerici, Gábor Király, Sophie Kitzmüller, Marigje Vernooij, Julia G. Zielinski  Journal of Investigative Dermatology  Volume 134, Issue 1, Pages 1-5 (January 2014) DOI: 10.1038/jid.2013.457 Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 Generation of genetically modified mice. (a) Embryonic stem (ES) cells are isolated from blastocysts of pregnant mice. These cells are pluripotent; i.e., they can differentiate to every cell type of the adult organism. The ES cells are taken into cell culture and grown in nutrient medium. The modified DNA (see b) is then transfected into the cells by a process called electroporation. Not all of the cells will take up the DNA. Therefore, the cells are treated with an antibiotic, normally neomycin, and only cells containing the modified DNA and thus expressing the neomycin-resistant gene (neo) will survive. The modified ES cells are subsequently injected into a mouse blastocyst embryo, which is implanted into the uterus of a surrogate mother. The surrogate mother will give birth to so-called chimeric mice because their tissues are derived from both the modified ES cells and the recipient embryo's ES cells. Further breeding of the chimeric mice will lead to homozygous genetically modified mice. (b) After the targeting construct is transfected into the ES cell, homologous recombination will replace exon 1 with the neo gene, which results in a nonfunctional wild-type gene. Journal of Investigative Dermatology 2014 134, 1-5DOI: (10.1038/jid.2013.457) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 Schematic illustration of the Cre-loxP system. To create a conditional knockout (KO) mouse, two independent mouse strains must be generated and crossed (Figure 1): a “Cre-mouse,” expressing the Cre recombinase under a chosen promoter that is specifically active in the tissue of interest, and a “floxed mouse.” In this example, exons 2 and 3 from the gene of interest are targeted and will be deleted. To this end, a target construct is introduced in embryonic stem cells, in which exons 2 and 3 are flanked by loxP sites, that also includes a neomycin-resistance gene placed in the intron between exons 2 and 3. The construct also contains flanking regions that are homologous to regions of the gene of interest. Upon transfection, homologous recombination results in replacement of the endogenous gene of interest sequences with the target sequence, resulting in floxed exons 2 and 3 and hence a floxed “gene X” mouse. Crossing of the Cre mouse with the floxed mouse now gives rise to offspring in which the Cre gene is expressed in tissues where the chosen promoter is active. Only in these tissues does loxP site-specific recombination take place, resulting in the deletion of exons 2 and 3 and thus in tissue-specific gene knockout. Journal of Investigative Dermatology 2014 134, 1-5DOI: (10.1038/jid.2013.457) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 Knockout and genotyping PCR. (a) Exons (E) 2 and 3 of the Acvr1b gene are flanked by loxP sites. Primers (P) 1–5 were designed for genotyping PCR. (b) Acvr1b genotyping using P1/P2 or P3/P4. The upper bands include a loxP site and are therefore bigger than the wild-type allele (lower bands). (c) PCR with primers P4/P5 detecting the recombined DNA and confirming that it is recombined only when Cre is expressed under the K14 promoter. (d) PCR with P4/P5 indicating in which tissue the recombination occurred (Qiu et al., 2011). Journal of Investigative Dermatology 2014 134, 1-5DOI: (10.1038/jid.2013.457) Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Journal of Investigative Dermatology 2014 134, 1-5DOI: (10. 1038/jid Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions

Journal of Investigative Dermatology 2014 134, 1-5DOI: (10. 1038/jid Copyright © 2014 The Society for Investigative Dermatology, Inc Terms and Conditions